Hereditary xanthinuria

0
Hereditary xanthinuria

Hereditary xanthinuria is a rare genetic disorder associated with a purine metabolism disorder and characterized by increased intracellular concentrations of xanthine and other hypoxanthines. The disease occurs as a result of a defect in the enzyme xanthine oxidase, which leads to a disruption in the oxidation of hypoxanthine to xanthine and then to uric acid. Unlike many other conditions associated with uric acid metabolism, in hereditary xanthinuria, uric acid levels in the blood remain low or normal, making diagnosis difficult. Symptoms include the formation of xanthine in the urinary tract, which can lead to nephrolithiasis and, in some cases, renal failure. Almost all patients are male, indicating a recessive type of inheritance.

History of the disease and interesting historical facts

The history of hereditary xanthinuria research dates back to the mid-20th century, when doctors discovered abnormalities in xanthine metabolism in individual patients. In 1963, the link between xanthine oxidase deficiency and the development of xanthinuria was first described. Of particular interest is the fact that symptoms often appear in patients during adolescence, which can lead to significant problems in explaining their condition. One historical fact is that in the 1980s, a hypothesis was formulated in Japan about a possible link between xanthinuria and certain dietary habits, but the scientifically proven significance of this link remains a subject of debate.

Epidemiology

Data on the prevalence of hereditary xanthinuria are very limited due to the rarity of the disease. Estimates put the incidence at 1 in 100,000, although the actual incidence may vary by region and population. Studies show that hereditary xanthinuria occurs with varying prevalence among different ethnic groups. Screening measures may increase the number of cases detected, but it is important to note that the disease is more common in males due to its recessive inheritance on the X chromosome.

Genetic predisposition to this disease

Hereditary xanthinuria is caused by mutations in the XQ26 gene, which codes for the enzyme xanthine oxidase. In most cases, these are recessive mutations, which means that they occur predominantly in males who inherited the mutation from their mother. Description of the identified mutations shows that they can range from point changes to larger deletions. Understanding the genetic basis of the disease opens up new horizons for diagnosis and treatment. Observations show that many patients have a family history, which also emphasizes the importance of genetic counseling to identify potential cases in families.

Risk factors for the development of this disease

The main risk factor for hereditary xanthinuria is having close relatives with a similar disease, which indicates its hereditary nature. Additional factors that increase the likelihood of diagnosis include the following:

  • A genetic predisposition associated with abnormalities in genes that control purine metabolism.
  • Improper nutrition, which can provoke metabolic disorders.
  • Specific microbial infections that may increase purine intake.

Diagnosis of this disease

Diagnosis of hereditary xanthinuria is based on a number of clinical and laboratory tests. The main symptoms include:

  • Pain in the lumbar region.
  • Frequent urge to urinate.
  • Presence of xanthine crystals in urine.

Key laboratory tests are:

  • Biochemical analysis of urine for the presence of xanthine crystals.
  • Determination of uric acid levels in blood serum.

Radiological examination may include ultrasound of the kidneys and urinary tract to determine the presence of stones or other abnormalities. When making a diagnosis, it is important to differentiate hereditary xanthinuria from other conditions such as hyperuricemia or other metabolic disorders.

Treatment

Treatment for hereditary xanthinuria is aimed at reducing xanthine levels in the body and relieving symptoms. Key approaches include:

  • Pharmacological treatment using allopurinol to reduce xanthine synthesis.
  • Dietary modifications that limit purine intake reduce the risk of stone formation.
  • Surgical treatment in case of presence of large stones in the urinary tract.

Other treatments may include replacement therapy and monitoring to prevent complications. A comprehensive approach to treatment allows patients to have a high quality of life and minimize the manifestations of the disease.

List of medications used to treat this disease

The main drugs used to treat hereditary xanthinuria include:

  • Allopurinol - used to reduce xanthine levels.
  • Febuxostat is an alternative drug for controlling purine levels.
  • Diuretics to improve the excretion of xanthine in the urine.

Disease monitoring

Monitoring of hereditary xanthinuria involves regular assessment of xanthine and uric acid levels, as well as monitoring of kidney function. The prognosis for most patients is favorable, provided that treatment and dietary recommendations are followed. However, complications may develop, such as:

  • Renal failure.
  • Increased susceptibility to urinary tract infections.

These complications may require additional medical intervention and monitoring.

Age-related features of the disease

Hereditary xanthinuria usually manifests itself in young age, with symptoms starting in adolescence. In newborns and infants, the disease may not manifest itself clearly, which makes early diagnosis difficult. In adulthood, without proper treatment, the risk of complications increases, which is confirmed by clinical studies indicating an increase in the incidence of complications in the group of patients over 40 years of age.

Questions and Answers

  • What is hereditary xanthinuria? This is a rare genetic disorder caused by a deficiency of the enzyme xanthine oxidase, which leads to a disruption of xanthine metabolism and the formation of urinary stones.
  • How to diagnose hereditary xanthinuria? Diagnosis includes urine analysis for the presence of xanthine crystals and determination of the level of uric acid in the blood.
  • What treatment is available for hereditary xanthinuria? Treatment includes pharmacologic therapy (eg, allopurinol), dietary modification, and, in some cases, surgery.
  • What complications can arise from hereditary xanthinuria? Complications include kidney failure and urinary tract infections.
  • At what age does the disease usually appear? Hereditary xanthinuria usually appears in adolescence or young adulthood.

Dr. Oleg Korzhikov recommends paying special attention to the possibility of genetic counseling to identify potentially predisposed individuals among relatives. "It is very important to lead a healthy lifestyle and monitor your diet, limiting foods high in purines. This helps reduce the risk of complications and improve overall health," the doctor emphasizes. Therefore, it is important for patients to undergo regular examinations and not neglect the recommended therapy.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.